Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus

NCT02526524 is registered in ClinicalTrials.gov with Elcelyx Therapeutics, Inc. as lead sponsor.

NCT NCT02526524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02526524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus
Lead sponsor
Elcelyx Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2015
Completion date
September 30, 2016
Enrollment
571 (actual)
Sites
137

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus